Insulin Delivery Devices Market Growth, Size, Trends, Demand, Revenue, Share and Future Outlook

Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Feb 2024 Report ID: HLCA2417 Pages: 1 - 224 Formats*:     
Category : Healthcare
Insulin Delivery Devices Market Introduction and Overview 

According to SPER Market Research, the Insulin Delivery Devices Market is estimated to reach USD 70.14 billion by 2033 with a CAGR of 8.71%.

The report includes an in-depth analysis of the Insulin Delivery Devices Market, including market size and trends, product mix, Applications, and supplier analysis. Insulin is a hormone produced by the pancreas' beta cells in the islets of Langerhans. The hormone maintains normal blood glucose levels by facilitating cellular glucose uptake and regulating carbohydrate, protein, and lipid metabolism. Inappropriate insulin function due to damaged beta cells or the body's inability to use the insulin produced can result in type I and type II diabetes.  

  • 2020: Medtronic launched InPen™ with real-time Guardian Connect™ CGM data.
  • 2019: Sanofi and Abbott have announced a non-exclusive collaboration to integrate glucose sensing and insulin delivery technologies to simplify diabetes management. Abbott's FreeStyle Libre mobile app and cloud software, as well as Sanofi's connected insulin pens, apps, and cloud software, are currently being developed.
Insulin Delivery Devices Market
Market Opportunities and Challenges

Opportunities- Technological advancements in insulin delivery devices, such as smart insulin pens and insulin pumps, as well as increased support from the US FDA, all contribute to global market growth.  The insulin delivery devices market is growing due to increasing consumer awareness of the availability of various delivery devices, the rising prevalence of hyperglycaemia, increased awareness about diabetes management and the importance of insulin delivery devices, and the rapid adoption of insulin therapy for diabetes management.

Challenges- The high costs associated with insulin delivery devices, which limit affordability for some patients, limited reimbursement coverage for certain types of insulin delivery devices, and stringent regulatory requirements and approval processes for new insulin delivery devices all impede global market growth.   

Insulin Delivery Devices Market


Market Competitive Landscape
Leading insulin delivery device companies are focusing on expanding their product portfolios through collaborations, mergers, and acquisitions, which will help them strengthen their global market presence. Some of the key players are - Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V. 

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Type, By End User.
 Regions coveredNorth America, Asia-Pacific, Latin America, Middle East & Africa and Europe
 Companies CoveredBiocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V. 
COVID-19 Impact on Insulin Delivery Devices Market
The COVID-19 pandemic poses a significant risk to people with diabetes. According to recent research, diabetes affects approximately 25% of people experiencing severe COVID-19 symptoms. High blood sugar levels weaken the immune system, while COVID-19 patients experience severe complications. As a result, demand for insulin delivery devices increased during the peak stage of COVID-19, causing a temporary acceleration in market growth. To avoid contracting the infection, many diabetic patients seek medical advice online and use cutting-edge technology.   

Key Target Audience
  • Diabetes Patients  
  • Government Health Departments and Regulatory Authorities 
  • Hospitals and Clinics  
  • Medical Device Manufacturers 
  • Patients Advocacy Groups   
  • Retail Pharmacies
  • Others
Our in-depth analysis of the Insulin Delivery Devices Market includes the following segments:
By Type:
  • Insulin Pens
  • Insulins Pumps
  • Insulin Syringes
  • Insulin Pen Needles
  • By End User:
  • Hospitals & Clinics
  • Patients & Homecare
  • By Region:
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • North America
  • Latin America
  • Key Topics Covered in the Report
    • Insulin Delivery Devices Market Size (FY’2023-FY’2033)
    • Overview of Insulin Delivery Devices Market
    • Segmentation of Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)).
    • Segmentation of Insulin Delivery Devices Market By End User (Hospitals & Clinics, Patients/Homecare).
    • Statistical Snap of Insulin Delivery Devices Market
    • Expansion Analysis of Insulin Delivery Devices Market
    • Problems and Obstacles in Insulin Delivery Devices Market
    • Competitive Landscape in the Insulin Delivery Devices Market
    • Impact of COVID-19 and Demonetization on Insulin Delivery Devices Market
    • Details on Current Investment in Insulin Delivery Devices Market
    • Competitive Analysis of Insulin Delivery Devices Market
    • Prominent Players in the Insulin Delivery Devices Market
    • SWOT Analysis of Insulin Delivery Devices Market
    • Insulin Delivery Devices Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Insulin Delivery Devices  Market

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Insulin Delivery Devices   Market 

    7. Insulin Delivery Devices Market, By Type (USD Million)
    7.1. Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-2033
    7.2. Insulin Pens
    7.3. Insulins Pumps
    7.4. Insulin Syringes
    7.5. Insulin Pen Needles

    8. Insulin Delivery Devices Market, By End User (USD Million)
    8.1. Insulin Delivery Devices Market Value Share and Forecast, By Vehicle type, 2023-2033
    8.2. Hospitals & Clinics
    8.3. Patients & Homecare

    9. Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)
    9.1. Insulin Delivery Devices  Market Size and Market Share

    10. Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)
    10.1. Insulin Delivery Devices  Market Size and Market Share By Type (2019-2026)
    10.2. Insulin Delivery Devices  Market Size and Market Share By Type (2027-2033)

    11. Insulin Delivery Devices Market, By End User, 2019-2033 (USD Million)
    11.1. Insulin Delivery Devices Market Size and Market Share By End User (2019-2026)
    11.2. Insulin Delivery Devices Market Size and Market Share By End User (2027-2033)

    12. Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)
    12.1. Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
    12.2. Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)
    12.3. Eastern Region
    12.4. Western Region
    12.5. Northern Region
    12.6. Southern Region

    13. Company Profile
    13.1.  Biocon Limited 
    13.1.1. Company details
    13.1.2. Financial outlook
    13.1.3. Product summary 
    13.1.4. Recent developments
    13.2. Diabetes Care Business   
    13.2.1. Company details
    13.2.2. Financial outlook
    13.2.3. Product summary 
    13.2.4. Recent developments
    13.3. Eli Lilly and Company 
    13.3.1. Company details
    13.3.2. Financial outlook
    13.3.3. Product summary 
    13.3.4. Recent developments
    13.4. Hindustan Syringes & Medical Devices Ltd.
    13.4.1. Company details
    13.4.2. Financial outlook
    13.4.3. Product summary 
    13.4.4. Recent developments
    13.5. Insulet Corporation 
    13.5.1. Company details
    13.5.2. Financial outlook
    13.5.3. Product summary 
    13.5.4. Recent developments
    13.6. Mannkind Corporation  
    13.6.1. Company details
    13.6.2. Financial outlook
    13.6.3. Product summary 
    13.6.4. Recent developments
    13.7. Sanofi  
    13.7.1. Company details
    13.7.2. Financial outlook
    13.7.3. Product summary 
    13.7.4. Recent developments
    13.8. Terumo Corporation  
    13.8.1. Company details
    13.8.2. Financial outlook
    13.8.3. Product summary 
    13.8.4. Recent developments
    13.9. Vicentra B.V.  
    13.9.1. Company details
    13.9.2. Financial outlook
    13.9.3. Product summary 
    13.9.4. Recent developments
    13.10. Others

    14. List of Abbreviations

    15. Reference Links

    16. Conclusion

    17. Research Scope


    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Insulin Delivery Devices Market is projected to reach USD 70.14 billion by 2033, growing at a CAGR of 8.71% during the forecast period.
    Insulin Delivery Devices Market grew in Market size from 2022. The Market is expected to reach USD 70.14 billion by 2033, at a CAGR of 8.71% during the forecast period.
    Insulin Delivery Devices Market CAGR of 8.71% during the forecast period.
    Insulin Delivery Devices Market size is USD 70.14 billion from 2023 to 2033.
    Insulin Delivery Devices Market Segment is covered By Type, By End User.
    The North America is anticipated to have the highest Market share in the Insulin Delivery Devices Market.
    The key players in the Market include Companies Covered Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V.
    The hormone maintains normal blood glucose levels by facilitating cellular glucose uptake and regulating carbohydrate, protein, and lipid metabolism.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650